With approval from the Health Sciences Authority (HSA), Tychan, a Singapore-based clinical-stage biotechnology com...
Gilead Sciences, Inc. has announced that the Health Sciences Authority of Singapore (HSA) has granted conditional approv...
The University of Tokyo, RIKEN, Nichi-Iko Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited have reached a ba...
Australian firm Atomo Diagnostics Limited is pleased to announce it has expanded its existing COVID-19 rapid test p...
Transmission of the novel coronavirus by people who don’t develop symptoms is “very rare,” the Wo...
uHoo, an air quality management company based in Singapore and Hong Kong, has launched the "uHoo Virus Index" - the worl...
Ministry of Health is very pleased to report no active cases of COVID-19 in New Zealand. The Ministry has been notified...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, o...
A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...
The Biotechnology Innovation Organization (BIO), the largest trade organization to serve and represent the eme...
UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...
The spread of the COVID-19 can be slowed by the use of interferon-lambda, which has the ability to inhibit replication o...
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...
US based company AbbVie, Harbour BioMed (HBM) with operations in US and China, Utrecht University (UU) in Europe and Era...
US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...
Taiwan on 5 June 2020 licenced it's first domestically-developed and produced antibody reagent for SARS-CoV-2 detec...
Singapore is reviewing the possibility to distribute a "portable contact tracing device" to assist in its meth...
Singapore Prime Minister Lee Hsien Loong announced on 5 June 2020 while participating in 'Global Vaccine Summit 2020' th...
